我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
隶属于 The University of Alabama System
相关临床试验
0
0 进行中
药物批准
批准总数
监管机构
监管机构数
成立时间
1969
暂无试验阶段数据
暂无试验数据
暂无批准数据
- Armata Pharmaceuticals announced a Journal of Molecular Biology paper presenting an integrative structural atlas of Ar-KM, a phiKMV-like bacteriophage targeting Pseudomonas aeruginosa. - Using cryo-electron microscopy, proteomics and bioinformatics, researchers captured three distinct phage particle states and built atomic models for eleven structural proteins at near-atomic resolution. - The work identifies an enzyme activity aiding bacterial cell envelope penetration and a previously unrecognized protein enabling coordinated genome release and delivery. - Armata said it is now extending cryo-EM reconstruction to its proprietary Staphylococcus aureus phages, following four publications characterizing its Pseudomonas phages.